Skip to content

study to understand the quality of life in patients undergoing cancer removal surgery for tumors deep inside the abdomen, involving removal of multiple organs and major blood vessels

To evaluate quality of life (QOL) in patients undergoing multivisceral resections and/or vascular resections for retroperitoneal sarcomas - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/092684
Enrollment
150
Registered
2025-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C480- Malignant neoplasm of retroperitoneum Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital, Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients who can be contacted in person or telephonically 2.All patients over 18-years of age, undergoing Multi-visceral resections for RP sarcomas 3.All patients undergoing Vascular resection (with/ without reconstructions) for RP sarcomas

Exclusion criteria

Exclusion criteria: 1. Other RP tumors (non-sarcomas) 2. Patients not willing to participate in the study/ cannot give a valid informed consent

Design outcomes

Primary

MeasureTime frame
To evaluate Long-term (more than 8 weeks) QOL in patients undergoing multivisceral and/or vascular resections for RP sarcomasTimepoint: ar 3 month and 6 month from date of surgery

Secondary

MeasureTime frame
To evaluate short-term outcomes (less than 8 weeks) as Post op morbidity (Clavien-Dindo Grade equal to or more than grade 3), Post-op Ileus, Acute renal failure, Diarrhoea, Clinically significant chyle leaks, Limb weakness, Lower limb edema, Length of ICU stay, ICU re-admission rates, Length of hospital stay, Hospital readmission rates, Re-operation rates, Fitness for adjuvant chemo Timepoint: after 3 months from the date of surgery

Countries

India

Contacts

Public ContactDr Akhila Mamidigi

Tata Memorial Hospital, Mumbai

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026